Who owns the OMBLASTYS (131 I-OMBURTAMAB-YCWD) trademark?

The OMBLASTYS (131 I-OMBURTAMAB-YCWD) trademark is owned by Y-mAbs Therapeutics, Inc.

What class is the OMBLASTYS (131 I-OMBURTAMAB-YCWD) trademark registered in?

The OMBLASTYS (131 I-OMBURTAMAB-YCWD) trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

What is the serial number for OMBLASTYS (131 I-OMBURTAMAB-YCWD)?

The USPTO serial number for OMBLASTYS (131 I-OMBURTAMAB-YCWD) is 79358602.

What is the registration number for OMBLASTYS (131 I-OMBURTAMAB-YCWD)?

OMBLASTYS (131 I-OMBURTAMAB-YCWD) is registered under USPTO registration number 7341739.

OMB

USPTO Trademark Record

REGISTERED

OMBLASTYS (131 I-OMBURTAMAB-YCWD)

SN 79358602·Reg 7341739·Filed Oct 17, 2022

Owner Y-mAbs Therapeutics, Inc

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

OMBLASTYS (131 I-OMBURTAMAB-YCWD) (Serial No. 79358602), Registration No. 7341739, is a registered US trademark filed on Oct 17, 2022 by Y-mAbs Therapeutics, Inc. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

early section 8: April 02, 2030

Mark Intelligence

OMBLASTYS (131 I-OMBURTAMAB-YCWD) (Reg. #7341739) is a registered US trademark that has been protecting its owner, Y-mAbs Therapeutics, Inc, since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Oct 17, 2022

SERIAL

79358602

REG#

7341739

REGISTERED

Apr 02, 2024

Owner

Applicant

Y-mAbs Therapeutics, Inc

Entity

Corporation

State

Address

230 Park Avenue, Suite 3350, New York NY 10169

Country

Attorney

NameAndrew N. Spivak

Law firm

Andrew N. Spivak Mosaic Legal Group, PLLC

Docket

26691

Address

5185 MacArthur Boulevard, NW, Suite 350, Washington, DC 20016-3341, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateOct 17, 2022

Serial Number79358602

Registration No.7341739

Registration DateApr 02, 2024

Status DateApr 02, 2024

Published for OppositionJan 16, 2024

Mark TypeDesign with words

Attorney Docket26691

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 3× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

31 events

NEW REPRESENTATIVE AT IB RECEIVED

Nov 20, 2025

NEW REPRESENTATIVE AT IB RECEIVED

FINAL DECISION TRANSACTION PROCESSED BY IB

Nov 09, 2024

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Oct 17, 2024

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Oct 17, 2024

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jul 03, 2024

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Apr 02, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 02, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Jan 16, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 16, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Jan 13, 2024

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 27, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Dec 27, 2023

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Dec 27, 2023

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 09, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Dec 08, 2023

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Dec 08, 2023

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Dec 08, 2023

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Dec 08, 2023

EXAMINER'S AMENDMENT ENTERED

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 31, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 30, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 30, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

REFUSAL PROCESSED BY IB

Sep 18, 2023

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Aug 31, 2023

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Aug 31, 2023

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Aug 11, 2023

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Aug 10, 2023

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Aug 01, 2023

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Jan 03, 2023

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 30, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Dec 28, 2022

LIMITATION FROM ORIGINAL APPLICATION ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Dec 23, 2022

SN ASSIGNED FOR SECT 66A APPL FROM IB

OMBLASTYS (131 I-OMBURTAMAB-YCWD)

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Y-mAbs Therapeutics, Inc

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Andrew N. Spivak

Resources

Company